1. Home
  2. BWXT vs CORT Comparison

BWXT vs CORT Comparison

Compare BWXT & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BWX Technologies Inc.

BWXT

BWX Technologies Inc.

HOLD

Current Price

$174.85

Market Cap

15.4B

Sector

N/A

ML Signal

HOLD

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$88.23

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWXT
CORT
Founded
1867
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
7.6B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BWXT
CORT
Price
$174.85
$88.23
Analyst Decision
Buy
Strong Buy
Analyst Count
10
5
Target Price
$183.45
$139.00
AVG Volume (30 Days)
1.1M
663.7K
Earning Date
11-03-2025
11-04-2025
Dividend Yield
0.57%
N/A
EPS Growth
10.60
N/A
EPS
3.34
0.87
Revenue
$3,058,850,000.00
$741,172,000.00
Revenue This Year
$18.91
$23.79
Revenue Next Year
$16.08
$40.97
P/E Ratio
$52.41
$99.75
Revenue Growth
14.01
17.92
52 Week Low
$84.21
$49.00
52 Week High
$218.50
$117.33

Technical Indicators

Market Signals
Indicator
BWXT
CORT
Relative Strength Index (RSI) 42.15 68.54
Support Level $172.25 $81.31
Resistance Level $183.94 $87.19
Average True Range (ATR) 5.65 2.86
MACD 0.87 0.74
Stochastic Oscillator 36.56 93.81

Price Performance

Historical Comparison
BWXT
CORT

About BWXT BWX Technologies Inc.

BWX Technologies Inc is a specialty manufacturer and service provider of nuclear components, operating in two segments: Government Operations and Commercial Operations. The Government Operations segment produces naval nuclear reactors and fuel for the U.S. Naval Nuclear Propulsion Program, while the Commercial Operations segment designs and manufactures commercial nuclear steam generators, heat exchangers, pressure vessels, reactor components, and other auxiliary equipment, including containers for the storage of spent nuclear fuel and other high-level nuclear waste. The majority of the company's revenue comes from Government Operations, with sales principally in the United States, Canada, and other regions.

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

Share on Social Networks: